Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1

Abstract

THE Epstein–Barr virus (EBV)-encoded nuclear antigen (EBNA1) is expressed in latently EBV-infected B lymphocytes that persist for life in healthy virus carriers1,2, and is the only viral protein regularly detected in all malignancies associated with EBV3,4. Major histocompatibility complex (MHC) class I-restricted, EBNA1-specific cytotoxic T lymphocyte (CTL) responses have not been demonstrated3,5. Using recombinant vaccinia viruses encoding chimaeric proteins containing an immunodominant human leukocyte antigen All-restricted CTL epitope, amino acids 416–424 of the EBNA4 protein6, inserted within the intact EBNA1, or within an EBNA1 deletion mutant devoid of the internal Gly–Ala repetitive sequence, we demonstrate that the Gly–Ala repeats generate a cis-acting inhibitory signal that interferes with antigen processing and MHC class I-restricted presentation. Insertion of the Gly–Ala repeats downstream of the 416–424 epitope inhibited CTL recognition of a chimaeric EBNA4 protein. The results highlight a previously unknown mechanism of viral escape from CTL surveillance, and support the view that the resistance of cells expressing EBNA1 to rejection mediated by CTL is a critical requirement for EBV persistence and pathogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tierney, R. J., Steven, N., Young, L. S. & Rickinson, A. B. J. Virol. 68, 7374–7385 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Chen, F. et al. J. Virol (in the press).

  3. Masucci, M. G. & Ernberg, I. Trends Microbiol. 2, 125–130 (1994).

    Article  CAS  PubMed  Google Scholar 

  4. Klein, G. Cell 77, 791–793 (1994).

    Article  CAS  PubMed  Google Scholar 

  5. Rickinson, A. et al. in A New Look at Tumor Immunology (eds McMichael, A. & Franks, L.) 53–80 (Cold Spring Harbor Laboratory Press, New York, 1992).

    Google Scholar 

  6. Gavioli, R. et al. J. Virol. 67, 1572–1578 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Rawlins, D. R., Milman, G., Hayward, D. S. & Haywards, G. S. Cell 42, 859–868 (1985).

    Article  CAS  PubMed  Google Scholar 

  8. Baer, R. et al. Nature 310, 207–211 (1984).

    Article  ADS  CAS  PubMed  Google Scholar 

  9. Dillner, J. et al. Proc. natn. Acad. Sci. U.S.A. 81, 4652–4656 (1984).

    Article  ADS  CAS  Google Scholar 

  10. de Campos-Lima, P. O. et al. J. exp. Med. 179, 1297–1305 (1994).

    Article  CAS  PubMed  Google Scholar 

  11. Steigewald-Mullen, P. M. & Kurilla, M. G. J. gen. Virol. (in the press).

  12. Bangham, C. R. M. et al. J. Immun. 137, 3973–3977 (1986).

    CAS  PubMed  Google Scholar 

  13. Lee, P. & Hruby, D. E. J. Virol. 67, 4252–4263 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Murray, R. et al. J. exp. Med. 176, 157–168 (1992).

    Article  CAS  PubMed  Google Scholar 

  15. Michalek, M. T., Grant, E. P., Gramm, C., Goldberg, A. L. & Rock, K. L. Nature 363, 552–554 (1993).

    Article  ADS  CAS  PubMed  Google Scholar 

  16. Rock, K. L. et al. Cell 78, 761–771 (1994).

    Article  CAS  PubMed  Google Scholar 

  17. Ciechanover, A. Cell 79, 13–21 (1994).

    Article  CAS  PubMed  Google Scholar 

  18. Tsubota, H., Lord, C. I., Watkins, D. I., Morimoto, C. & Letvin, N. L. J. exp. Med. 169, 1421–1434 (1989).

    Article  CAS  PubMed  Google Scholar 

  19. Lukacher, A. E., Braciale, V. L. & Braciale, T. J. J. exp. Med. 160, 814–826 (1984).

    Article  CAS  PubMed  Google Scholar 

  20. Byrne, J. A. & Oldstone, M. B. A. J. Virol. 51, 682–686 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Burgert, H. G., Maryansky, J. L. & Kvist, S. Proc. natn. Acad. Sci. U.S.A. 84, 1356–1359 (1987).

    Article  ADS  CAS  Google Scholar 

  22. Phillips, R. et al. Nature 354, 453–459 (1991).

    Article  ADS  CAS  PubMed  Google Scholar 

  23. Pircher, H. et al. Nature 346, 629–633 (1990).

    Article  ADS  CAS  PubMed  Google Scholar 

  24. Klenerman, P. et al. Nature 369, 403–407 (1994).

    Article  ADS  CAS  PubMed  Google Scholar 

  25. Bertoletti, A. et al. Nature 369, 407–410 (1994).

    Article  ADS  CAS  PubMed  Google Scholar 

  26. Tishon, A., Borrow, P., Evans, C. & A., O. M. B. Virology 195, 397–405 (1993).

    Article  CAS  PubMed  Google Scholar 

  27. Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. M. Nature 362, 758–761 (1993).

    Article  ADS  CAS  PubMed  Google Scholar 

  28. Reedman, B. M. & Klein, G. Int. J. Cancer 11, 499–520 (1973).

    Article  CAS  PubMed  Google Scholar 

  29. Chen, M.-R., Middletorp, J. M. & Hayward, D. J. Virol. 67, 4875–4885 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levitskaya, J., Coram, M., Levitsky, V. et al. Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1. Nature 375, 685–688 (1995). https://doi.org/10.1038/375685a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/375685a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing